Stephen P Hibbs

Sep 14, 2024 | bmj.com | Stephen P Hibbs

Dear EditorI have worked as a postgraduate doctor in training for twelve years, mostly within a specialty tied to significant pharmaceutical profits. Alice Fabbri and Quinn Grundy make a compelling case for challenging industry involvement and improving education for early-career physicians [1]. I fully agree, and I’d like to share my own observations and growing confusion about pharmaceutical influence in medical spaces. What have I learned?

Sep 11, 2024 | jamanetwork.com | Stephen P Hibbs |Laura Aiken |NHS Blood |Lauren E. Merz

Key PointsQuestion  Do cancer clinical trials and anticancer regimens restrict participation of individuals with Duffy null–associated absolute neutrophil counts (DANCs) by setting exclusions and dose modifications within their neutrophil reference range?

Sep 4, 2024 | bmj.com | Stephen P Hibbs

Intended for healthcare professionals News & ViewsThe unsung generosity...

Jul 30, 2024 | bmj.com | Stephen P Hibbs

Dear Editor,The investigative feature by Jacklin Kwan on private cord blood banking illuminates a troubling and misleading practice, frequently promoted within NHS spaces. This profit-driven approach of storing stem cells for vague future use detracts from the extraordinary benefits of cord blood donation, which facilitates lifesaving acts of generosity across borders and generations. For patients with acute leukaemia, an allogeneic stem cell transplant is often crucial for a cure.

Feb 20, 2024 | bmj.com | Stephen P Hibbs

Intended for healthcare professionals News & ViewsCuriosity and...